Clinical Trial Update: CAR-37 T Cells in Hematologic Malignancies [Phase 1]

View source ↗

Summary

Phase 1 trial update on CAR-37 T cells in hematologic malignancies shows the study has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• B-cell Lymphoma
• Leukemia
• Non-hodgkin Lymphoma
• T-cell Lymphoma

Drugs mentioned

• CAR-37 T Cells

Snippet

Sponsor: Marcela V. Maus, M.D.,Ph.D. | Conditions: Hematologic Malignancy, Leukemia | Phase 1 | Status: COMPLETED